See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

ProMIS Neurosciences Announces Private Placement Financing

Summary by The Toronto Star
TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 28, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to discovery and development of therapeutic antibodies targeting toxic misfolded proteins in neurodegenerative diseases, such as Alzhiemer’s disease (AD),…

4 Articles

Eagle-TribuneEagle-Tribune
+3 Reposted by 3 other sources
Center

ProMIS Neurosciences Announces Private Placement Financing

TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 28, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to discovery and development of therapeutic antibodies targeting toxic misfolded proteins in neurodegenerative diseases, such as Alzhiemer’s disease (AD),…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources lean Left
75% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Orangeville broke the news in Orangeville, Canada on Monday, July 28, 2025.
Sources are mostly out of (0)

Similar News Topics

Cambridge, Massachusetts icon

Cambridge, Massachusetts

News
For You
SearchBlindspotLocal